This study tested a new COVID-19 vaccine called GEO-CM04S1 in 119 healthy adults. The goal was to check its safety and find the best dose to trigger a strong immune response. The vaccine uses a modified virus to teach the body to fight SARS-CoV-2, the virus that causes COVID-19.
Phase: PHASE1, PHASE2 • Sponsor: GeoVax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:05 UTC